We've detected an Ad Blocker in your browser.

Please disable or pause the Ad Blocker and refresh the page to be able to register and access the website normally.

Where Do Potent P2Y12 Inhibitors Fit Into Current Practice?

BROADCAST SERIES

This broadcast series is supported by an unrestricted educational grant from AstraZeneca


Register Now For Free

Log in

Already registered? Please log in using your email address.

Please enter your email address

Having trouble logging in? Please email info@radcliffe-group.com

validation result

Please choose one of the options shown

Please enter your registration lead id

Please enter your registration session id

Please enter your successful log-in count

first log-in conversion cutoff date (yyyy-mm-dd)

Please choose one of the options shown

event count (i.e. for event number 3, enter 3)

Please choose one of the options shown

on-demand log-in

Please choose one of the options shown

DAYS
:

HOURS
:

MINS
:

SECS

Programme Overview

This broadcast series Where Do Potent P2Y12 Inhibitors Fit Into Current Practice? will reappraise potent P2Y12 inhibitors, as evidence accumulates to support their broader use. At this juncture, there is still some uncertainty around patient selection, initiation and long-term management.

Join us as we consider current guidance, the landmark data, gaps in evidence and seek to provide practical guidance from experts in the field.

This programme is aimed at a target audience of General Cardiologists, Interventional Cardiologists, nurses, and any other allied HCPs.

There will be four broadcasts in this series focusing on the following key areas:

  • Acute Coronary Syndrome (ACS)
  • Chronic Coronary Syndrome (CCS)
  • Bleeding Mitigation Strategies
  • Stroke

Register now for the next broadcast in this series, Chronic Coronary Syndrome (CCS), live on Monday 26 September.

The first broadcast in this series, Acute Coronary Syndrome (ACS), is now available to watch on-demand.

Register Now


The next broadcast starts in:

DAYS
:

HOURS
:

MINS
:

SECS

Agenda

BROADCAST 1
NEXT EVENT

Acute Coronary Syndrome (ACS)

Date: Monday 27 June
Time: 13:00-14:30 BST

Learning objectives
  • Recall current unmet needs in ACS
  • Summarise current use of antiplatelet therapy in ACS according to guidelines
  • Describe the mode of action of potent P2Y12 inhibitors
  • Identify settings where a potent P2Y12 inhibitor should be used in favour of clopidogrel
  • Summarise the results of head-to-head trials between clopidogrel and potent P2Y12 inhibitors
  • Select appropriate assessment criteria for ischaemic risk and bleeding risk
  • Identify patients in whom a medical therapy only approach could be used over invasive strategies
  • Use antiplatelet therapy effectively and safely for long-term management of ACS

Faculty
Prof Robert F. Storey
University of Sheffield, UK
Dr Roxana Mehran - Panelist
Mount Sinai Hospital, New York, US
Dr Dominick J. Angiolillo - Panelist
University of Florida College of Medicine-Jacksonville, US

Prof Kurt Huber - Panelist
Clinic Ottakring, Vienna, AT

BROADCAST 2
NEXT EVENT

Chronic Coronary Syndrome (CCS)

Date: Monday 26 September
Time: 11:30 - 13:00 ET / 16:30 - 18:00 BST / 17:30 - 19:00 CEST

Learning objectives

Following the completion of this programme, physicians will be in a position to:

  • Discuss the disease burden in both primary and secondary prevention patients with high-risk features
  • Identify clinical features that make CCS patients high risk
  • Choose an appropriate antiplatelet regimen for CCS patients based on relevant history and current risk profile
  • Recall the results of RCTs using potent P2Y12 inhibitors in CCS patients with a prior MI and in patients with existing diabetes, with/without MI

Faculty
Prof Philippe Gabriel Steg - Chair & Panelist
Hospital Bichat-Claude Bernard, Paris, FR
Prof Eva Prescott - Panelist
Bispebjerg University Hospital, Copenhagen, DK
Dr Marc Bonaca - Panelist
University of Colorado School of Medicine, Aurora, US

Prof Deepak Bhatt - Panelist
Brigham and Women's Hospital, Boston, US

SHOW LESS

BROADCAST 3
NEXT EVENT

Bleeding Mitigation Strategies

More information coming soon

SHOW MORE +

+

BROADCAST 4
NEXT EVENT

Stroke

More information coming soon

SHOW MORE +

+

Register Now

Programme Faculty

Broadcast 1

Prof Robert F. Storey
Prof Robert F. Storey

Chair & Panelist

University of Sheffield, UK

Dr Dominick J. Angiolillo
Dr Dominick J. Angiolillo

Panelist

University of Florida College of Medicine-Jacksonville, US

Prof Kurt Huber
Prof Kurt Huber

Panelist

Clinic Ottakring, Vienna, AT

Dr Roxana Mehran
Dr Roxana Mehran

Panelist

Mount Sinai Hospital, New York, US

Broadcast 2

Philippe Gabriel Steg
Prof Philippe Gabriel Steg

Chair & Panelist

Hospital Bichat-Claude Bernard, Paris, FR

Deepak Bhatt
Prof Deepak Bhatt

Panelist

Brigham and Women's Hospital, Boston, US

Marc Bonaca
Dr Marc Bonaca

Panelist

University of Colorado School of Medicine, Aurora, US

Eva Prescott
Prof Eva Prescott

Panelist

Bispebjerg University Hospital, Copenhagen, DK

Register Now